Lifecore Biomedical, Inc.
LFCR
$4.54
$0.000.00%
NASDAQ
| 06/30/2026 | 05/25/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 47.32% | 3.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 47.32% | 3.67% | |||
| Cost of Revenue | 17.94% | -11.25% | |||
| Gross Profit | 170.62% | 42.02% | |||
| SG&A Expenses | 26.18% | -11.03% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.31% | -10.42% | |||
| Operating Income | 183.56% | 226.43% | |||
| Income Before Tax | 58.94% | 92.46% | |||
| Income Tax Expenses | -46.51% | 512.50% | |||
| Earnings from Continuing Operations | 58.91% | 92.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 58.91% | 92.23% | |||
| EBIT | 183.56% | 226.43% | |||
| EBITDA | 766.93% | 2,317.97% | |||
| EPS Basic | 55.39% | 88.22% | |||
| Normalized Basic EPS | 54.14% | 55.96% | |||
| EPS Diluted | 55.39% | 88.23% | |||
| Normalized Diluted EPS | 54.14% | 55.96% | |||
| Average Basic Shares Outstanding | 0.26% | -0.03% | |||
| Average Diluted Shares Outstanding | 0.26% | -0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||